A password will be e-mailed to you.

Motley Fool Co-Founders just released an exclusive report naming 5 of their favorite stocks to buy right now Whether you realize it or not, this is going to be a big year for the North American cannabis industry. Sure, history was made in 2018 with Canada launching recreational cannabis sales in licensed dispensaries, and the U.S. Food and Drug Administration (FDA) approving the very first cannabis-derived drug. But history is expected to be made later this year, too. According to recent updates from Health Canada, derivative pot products are set to launch in cannabis stores by mid-December. Don’t Hold Your Breath for the FDA’s CBD Report

thumbnail courtesy of fool.com